Stock listing

Helsinki:OPTOMED Optomed Oyj Osake

Home listing (Helsinki) of Optomed Oyj

Follow Optomed Oyj into a list and get an email when it puts out news.

Share price · OMXHEX:OPTOMED

€1.58 EUR -0.12 (-7.1%)

Close on Nov 20, 2026

Past year -60.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€1.51 – €1.63 EURNov 20, 2026
Volume
71,989 sharesNov 20, 2026
Market cap
€33.93M EURAt the close on Nov 20, 2026 · price × 21.47M shares outstanding
52-week range
€1.32 – €4.10 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€72,985 EURMedian day 31,636 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Optomed Oyj logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Helsinki:OPTOMED · Home€1.58 EUR-0.12 (-7.1%)71,989€1.632€1.632€1.506€1.70Close on Nov 20, 2026
Frankfurt:36U0€1.554 EUR-0.116 (-6.9%)—€1.554€1.554€1.554€1.67Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXHEX:OPTOMED · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.58-0.12-7.1%€1.632€1.632€1.50671,989
€1.70-0.056-3.2%€1.772€1.79€1.6746,458
€1.756-0.08-4.4%€1.864€1.90€1.756116,308
€1.836+0.176+10.6%€1.702€1.85€1.688179,600
€1.66-0.004-0.2%€1.662€1.71€1.65437,493
€1.664+0.004+0.2%€1.658€1.664€1.6241,847
€1.66-0.066-3.8%€1.694€1.694€1.6440,872
€1.726+0.214+14.2%€1.762€1.82€1.622385,323
€1.512+0.002+0.1%€1.51€1.588€1.5080,258
€1.51-0.016-1.0%€1.526€1.53€1.48642,016
€1.526+0.054+3.7%€1.472€1.534€1.46856,762
€1.472+0.062+4.4%€1.41€1.504€1.4165,102
€1.41+0.042+3.1%€1.368€1.41€1.32231,659
€1.368+0.016+1.2%€1.352€1.368€1.3313,631
€1.352-0.022-1.6%€1.372€1.374€1.33852,712
€1.374-0.008-0.6%€1.396€1.398€1.3715,442
€1.382-0.038-2.7%€1.43€1.43€1.3727,705
€1.42+0.032+2.3%€1.45€1.45€1.3712,282
€1.388-0.018-1.3%€1.412€1.436€1.38817,986
€1.406+0.046+3.4%€1.352€1.412€1.35228,039
€1.360.000.0%€1.36€1.386€1.35217,220
€1.36-0.046-3.3%€1.406€1.406€1.34431,628
€1.406+0.008+0.6%€1.40€1.424€1.3814,074
€1.398+0.006+0.4%€1.392€1.45€1.37816,451
€1.392-0.018-1.3%€1.396€1.40€1.3826,523
€1.41+0.038+2.8%€1.372€1.44€1.37225,294
€1.372-0.058-4.1%€1.43€1.43€1.3657,342
€1.43-0.026-1.8%€1.462€1.462€1.40223,579
€1.456+0.024+1.7%€1.43€1.488€1.4033,003
€1.432+0.046+3.3%€1.392€1.434€1.3841,028
€1.386-0.02-1.4%€1.39€1.422€1.38267,423
€1.406-0.054-3.7%€1.46€1.46€1.3867,455
€1.46-0.01-0.7%€1.472€1.472€1.396129,863
€1.47-0.04-2.6%€1.51€1.56€1.4722,257
€1.51-0.016-1.0%€1.526€1.53€1.5020,673
€1.526-0.02-1.3%€1.55€1.55€1.51618,315
€1.546-0.004-0.3%€1.548€1.552€1.52418,555
€1.55+0.026+1.7%€1.524€1.558€1.50419,908
€1.524-0.03-1.9%€1.562€1.562€1.518,908
€1.554+0.03+2.0%€1.52€1.562€1.49219,502
€1.524-0.022-1.4%€1.534€1.552€1.48117,980
€1.546+0.006+0.4%€1.54€1.57€1.52263,259
€1.54-0.02-1.3%€1.552€1.552€1.50469,289
€1.56-0.004-0.3%€1.566€1.598€1.55251,198
€1.564-0.016-1.0%€1.58€1.58€1.568,462
€1.58-0.002-0.1%€1.554€1.596€1.53431,843
€1.582+0.012+0.8%€1.56€1.598€1.5527,404
€1.57-0.024-1.5%€1.594€1.598€1.56426,020
€1.594-0.016-1.0%€1.61€1.61€1.5724,001
€1.61-0.01-0.6%€1.622€1.622€1.56250,672
€1.62-0.02-1.2%€1.64€1.652€1.61427,563
€1.640.000.0%€1.662€1.68€1.6264,777
€1.64+0.022+1.4%€1.62€1.648€1.60284,360
€1.618+0.018+1.1%€1.60€1.664€1.57831,644
€1.60-0.02-1.2%€1.64€1.642€1.5940,319
€1.62-0.038-2.3%€1.678€1.68€1.6239,256
€1.658-0.042-2.5%€1.69€1.69€1.65215,628
€1.70+0.038+2.3%€1.67€1.702€1.63826,468
€1.662-0.016-1.0%€1.70€1.70€1.65810,888
€1.678-0.028-1.6%€1.706€1.716€1.67832,911
€1.706+0.022+1.3%€1.708€1.72€1.6827,775
€1.684-0.012-0.7%€1.698€1.724€1.65823,259
€1.696+0.034+2.0%€1.646€1.702€1.6328,988
€1.662-0.016-1.0%€1.68€1.68€1.64622,531
Ticker
Helsinki:OPTOMED
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Helsinki
Currency
EUR

What changed lately

Latest news

All Optomed Oyj news

Optomed Oyj on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
12 in the last 12 months · 12 in all · newest Sep 25, 2026 · oldest 2025
Decks
35 decks · latest Nov 6, 2026

Where Optomed Oyj is listed

ListingExchangeCountryCurrency
Helsinki:OPTOMED · Home listing · This pageHelsinkiFinlandEUR
LS Exchange:A2PWGRLS ExchangeGermanyEUR
Aquis:OPTOMHAquisUnited KingdomEUR
Aquis:OPTOMHAquisUnited KingdomEUR
Dusseldorf:36U0DusseldorfGermanyEUR
Frankfurt:36U0FrankfurtGermanyEUR
Lang & Schwarz:A2PWGRLang & SchwarzGermanyEUR

Valuation

EV/sales 1.8× against a median of 1.3×: 7th lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
€29.59M EUR
P/E
Loss
EV/sales
1.8×
EV/EBITDA
Negative EBITDA
Price/book
1.6×
Gross margin
5.4%
Operating margin
−35.2%
Net margin
−33.9%
Debt to equity
0.1×
Beta
No index for this market yet

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Optomed Oyj Class A · OMXHEX:OPTOMEDUS$37.24MUS$32.48Mn/a1.8×n/a1.6×−33.9%0.1×n/a
electroCore, Inc. · NASDAQ:ECORUS$40.78MUS$41.51Mn/a1.1×n/an/a−33.5%n/a1.91
Elutia, Inc. · NASDAQ:ELUTUS$39.86MUS$18.87M0.7×1.5×n/a2.6×441.2%0.5×-0.06
DRGEM Corp. · KRX:263690US$38.81MUS$32.33M4.3×0.4×3.2×0.5×11.2%0.1×n/a
Cryofocus Medtech (Shanghai) Co. Ltd. Class H · HKEX:6922US$37.93MUS$29.03Mn/a2.0×n/a3.8×−40.1%0.0×n/a
Ocumetics Technology Corp · TSXV:OTCUS$37.38MUS$37.60Mn/an/an/an/an/an/a0.14
Sensus Healthcare, Inc. · NASDAQ:SRTSUS$37.20MUS$24.56Mn/a1.5×n/a1.1×−96.5%0.0×1.08
Epiminder Ltd. · ASX:EPIUS$36.57M−US$13.60Mn/an/an/a0.7×n/a0.0×n/a
Avita Corporation · TPEX:4735US$35.63MUS$14.80M5.1×0.5×4.4×1.0×23.8%0.0×n/a
SELVAS Healthcare, Inc. · KRX:208370US$35.56MUS$15.07M5.5×0.6×8.0×0.6×27.5%0.0×n/a
Taiwan Biomaterial Co., Ltd. · TPEX:6649US$35.55MUS$28.06M35.3×5.1×26.5×1.8×18.2%0.0×n/a
Median of the othersUS$37.29MUS$26.31M5.1×1.3×6.2×1.1×14.7%0.0×0.61

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
2.27 EUR · Analysts' mean
EPS, year to Dec 2026
-0.13 · 2 analysts
Revenue, year to Dec 2026
17.5M · 3 analysts

Team and board

Officers

OfficerRole
Juho HimbergCEO
Sakari KnuuttiChief Financial Officer
Laura PiilaVice President, Devices
Markku MyllyläVice President, Software

Board

DirectorRole
Catherine CalarcoMember of the Board of Directors
Kristiina LeppänenMember of the Board of Directors
Leana WenMember of the Board of Directors
Petri SalonenDirector
Reijo TauriainenMember of the Board of Directors
Sameer BadlaniMember of the Board of Directors
Seppo MäkinenMember of the Board of Directors
Ty LeeMember of the Board of Directors

Events

Next results
Feb 18, 2027 (expected)
QuarterResultsShare move
Quarter to Sep 30, 2026Nov 6, 2026 · Before open+14.2%
Q2 2026Aug 14, 2026 · Before open−3.5%
Q1 2026May 6, 2026 · Before open−30.6%
Q4 2025Feb 10, 2026 · Before open−25.5%
Q3 2025Nov 6, 2025 · Before open+2.6%
Q2 2025Aug 7, 2025 · Before open−11.0%
Q1 2025May 6, 2025 · Before open+8.5%
Q4 2024Feb 13, 2025 · Before open+7.6%
Q3 2024Nov 7, 2024 · Before open+17.6%
Q2 2024Aug 8, 2024 · Before open−11.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · Before open+3.9%
Q4 2023Feb 15, 2024 · Before open−4.9%
Q3 2023Nov 3, 2023 · Before open+5.2%
Q2 2023Aug 4, 2023 · Before open−6.0%
Q1 2023May 5, 2023 · Before open−1.2%
Q4 2022Feb 17, 2023 · Before open−5.3%
Q3 2022Nov 3, 2022 · Before open+21.3%
Q2 2022Aug 4, 2022 · Before open+3.9%
Q1 2022May 5, 2022 · Before open−4.6%
Q4 2021Feb 17, 2022 · Before open−11.6%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings16 slidesNov 6, 2026
Q2 2026 Earnings PresentationEarnings16 slidesAug 14, 2026
Q4 2025 Earnings PresentationEarnings16 slidesFeb 10, 2026
Q3 2025 Earnings PresentationEarnings16 slidesNov 6, 2025
Q2 2025 Earnings PresentationEarnings16 slidesAug 7, 2025
Q1 2025 Earnings PresentationEarnings11 slidesMay 6, 2025
Investor Presentation (March 2025)Investor deck12 slidesMarch 2025
Q4 2024 Earnings PresentationEarnings15 slidesFeb 13, 2025
Q3 2024 Earnings PresentationEarnings15 slidesNov 7, 2024
Q2 2024 Earnings PresentationEarnings15 slidesAug 8, 2024
All 35 decks
DeckKindSlidesDate
Investor Presentation (June 2024)Investor deck10 slidesJune 2024
Q1 2024 Earnings PresentationEarnings12 slidesMay 10, 2024
Q4 2023 Earnings PresentationEarnings15 slidesFeb 15, 2024
Q3 2023 Earnings PresentationEarnings15 slidesNov 3, 2023
Q2 2023 Earnings PresentationEarnings15 slidesAug 4, 2023
Q1 2023 Earnings PresentationEarnings14 slidesMay 5, 2023
Q4 2022 Earnings PresentationEarnings16 slidesFeb 17, 2023
Nordic American Life Science Conference 2022Conference7 slidesDec 1, 2022
Q3 2022 Earnings PresentationEarnings16 slidesNov 3, 2022
Investor Presentation (November 2022)Investor deck18 slidesNovember 2022
Q2 2022 Earnings PresentationEarnings19 slidesAug 4, 2022
Q1 2022 Earnings PresentationEarnings15 slidesMay 5, 2022
Investor Presentation (April 2022)Investor deck17 slidesApril 2022
Investor Presentation (March 2022)Investor deck16 slidesMarch 2022
Q4 2021 Earnings PresentationEarnings22 slidesFeb 17, 2022
Q3 2021 Earnings PresentationEarnings20 slidesNov 4, 2021
Q2 2021 Earnings PresentationEarnings21 slidesAug 5, 2021
Q1 2021 Earnings PresentationEarnings17 slidesMay 6, 2021
Q4 2020 Earnings PresentationEarnings22 slidesFeb 18, 2021
Technical Presentation (2021)Technical16 slides2021
Q3 2020 Earnings PresentationEarnings22 slidesNov 25, 2020
Q2 2020 Earnings PresentationEarnings22 slidesAug 27, 2020
Redeye Growth Day 2020Conference12 slidesJun 2, 2020
Q1 2020 Earnings PresentationEarnings16 slidesMay 29, 2020
FY2019 Earnings PresentationEarnings24 slidesFeb 28, 2020

Open Decks

Financings

RaiseDateIn US dollars
Private placement of new shares (directed share issue)
Closed: €6M raised · €3.4 a share · UB Asset Management Ltd +1
Dealers: UB Asset Management Ltd (lead), UB Clairfield Corporate Finance Ltd
Use of proceeds: Ramp up production, start regulatory clearance processes (incl. clinical trials for Lumo AI in the US), improve sales and expand AI services globally
Dec 10, 2025US$6.99M

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue17.1M15.0M15.1M14.7M14.8M13.0M15.0M14.5M6.90M6.61M
Cost of revenue17.5M5.37M4.86M5.45M5.10M4.21M5.29M4.95M3.12M2.99M
Gross profit-370.0K9.67M10.2M9.21M9.75M8.80M9.69M9.51M3.78M3.62M
Research and development1.64M297.0K2.95M361.0K412.0K276.0K356.0K1.07M227.0K532.0K
Selling, general and administrative1.63M3.20M2.51M765.0K866.0K714.0K504.0K1.65M220.0K251.0K
Operating income-6.05M-5.96M-3.97M-4.67M-4.37M-2.75M-2.21M-665.0K-2.83M-2.61M
Depreciation and amortization2.52M2.50M2.19M3.15M2.69M2.17M2.26M1.81M1.04M746.0K
EBITDA-3.53M-3.46M-1.78M-1.53M-1.68M-572.0K51.0K1.15M-1.78M-1.86M
Interest expense1.26M776.0K288.0K268.0K165.0K171.0K365.0K594.0K197.0K89.0K
Income before tax-6.72M-5.52M-4.52M-5.55M-4.33M-3.25M-2.95M-1.22M-2.89M-2.76M
Income tax-77.0K-66.0K-78.0K-79.0K-78.0K-70.0K-77.0K48.0K-3.00K-3.00K
Net income-6.64M-5.45M-4.44M-5.47M-4.25M-3.18M-2.88M-1.27M-2.89M-2.76M
Earnings per share, basic-0.34-0.29-0.27-0.37-0.32-0.24-0.32-0.10-0.22-0.21

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents9.91M10.5M7.12M8.52M6.80M10.6M18.9M2.00M1.03M1.62M
Receivables3.47M3.27M3.19M4.57M4.63M3.64M4.13M3.40M962.0K1.02M
Inventory2.38M1.96M2.82M3.00M2.94M2.54M2.47M1.12M1.06M1.58M
Current assets15.8M15.7M13.1M16.1M14.4M16.8M25.5M6.52M3.71M4.95M
Property, plant and equipment2.11M2.11M2.18M2.30M1.64M1.52M1.48M1.82M
Goodwill4.26M4.26M4.26M4.26M4.26M4.26M4.26M4.26M
Total assets32.0M31.8M29.1M31.3M29.0M31.1M39.6M21.1M9.92M10.0M
Accounts payable1.16M891.0K782.0K869.0K944.0K595.0K1.67M732.0K522.0K668.0K
Current liabilities6.59M5.58M5.05M5.23M4.91M3.49M7.56M10.5M2.70M2.90M
Long-term debt371.0K1.31M2.36M4.29M5.75M6.19M8.10M2.99M4.96M
Total debt2.71M3.81M4.86M6.74M8.23M7.72M11.0M11.3M6.15M3.79M
Total liabilities7.96M8.14M8.72M11.0M11.9M11.0M17.0M15.6M8.76M6.50M
Shareholders' equity24.0M23.6M20.4M20.3M17.1M20.1M22.6M5.55M1.16M3.52M
Shares outstanding19.8M18.7M16.7M14.6M13.4M13.3M8.94M13.2M13.2M13.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-2.48M-1.60M-615.0K-2.37M-2.94M-2.80M161.0K-76.0K-766.0K-810.0K
Capital spending-2.36M-2.12M-2.41M-3.03M-2.57M-1.82M-1.44M-1.70M-1.93M-1.91M
Free cash flow-4.84M-3.71M-3.03M-5.40M-5.51M-4.62M-1.27M-1.77M-2.69M-2.72M
Cash from investing-2.36M-2.12M-2.41M-3.03M-2.57M-1.82M-1.43M-8.77M-1.91M-1.89M
Cash from financing4.19M7.08M1.61M7.00M1.64M-3.70M18.1M9.81M2.14M1.50M
Share buybacks5.98M9.18M4.31M9.01M1.01M92.0K
Change in cash-558.0K3.35M-1.41M1.72M-3.80M-8.26M16.9M968.0K-589.0K-1.20M

Open Financials

Cap table

Built by 6ix from Optomed Oyj Class A’s releases · as of Dec 10, 2025

Common shares
21,473,869
Fully diluted
21,473,869

Fully diluted

LineShares
Common shares21,473,869

Share count over time

CountShares
Nov 22, 202621,473,869

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Catherine CalarcoMember of the Board of Directors · Since at least May 8, 2026
Juho HimbergCEO · Since at least Sep 21, 2026
Kristiina LeppänenMember of the Board of Directors · Since at least May 8, 2026
Laura PiilaVice President, Devices · Since at least Nov 5, 2026
Leana WenMember of the Board of Directors · Since at least May 8, 2026
Markku MyllyläVice President, Software · Since at least Jan 21, 2026
Petri SalonenChairman of the Board of Directors · Since at least Sep 25, 2026
Reijo TauriainenMember of the Board of Directors · Since at least May 8, 2026
Sakari KnuuttiChief Financial Officer · Since at least Aug 14, 2026
Sameer BadlaniMember of the Board of Directors · Since at least May 8, 2026
All 12 people
PersonSeat
Seppo MäkinenMember of the Board of Directors · Since at least May 8, 2026
Ty LeeMember of the Board of Directors · Since at least May 8, 2026

Open People

Log in to ask 6ix AI your own questions about Optomed Oyj.